Glenmark Pharma gets shareholders' nod to raise up to $200 million

30 Sep 2019 Evaluate

Glenmark Pharmaceuticals has received shareholders' approval to raise up to $200 million (about Rs 1,413 crore) through issuance of debt securities. The proposal was approved at the company's annual general meeting held on September 27, 2019.

According to the proposal, the company planning to raise up to $200 million in Indian and/or international market through bonds, debentures or other debt securities in one or more tranches.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1043.00 23.45 (2.30%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.